Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uveal Melanoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 201 Breast Neoplasms 111 Neoplasms 88 Prostatic Neoplasms 33 Fatigue 28 Obesity 22 Colorectal Neoplasms 19 Lung Neoplasms 16 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 10 Lymphedema 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Hematologic Neoplasms 8 Cardiotoxicity 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Cognitive Dysfunction 6 Brain Neoplasms 6 Overweight 5 Inflammation 5 Cachexia 5 Stomach Neoplasms 4

Interventions

Ipilimumab 14 Nivolumab 12 incomplete Freund's adjuvant 8 Cyclophosphamide 7 pembrolizumab 6 Ranibizumab 6 CTLA-4 Antigen 6 sargramostim 5 Radiosurgery 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 MART-1 Antigen 4 Biopsy 4 tebentafusp 3 aflibercept 3 Temozolomide 3 Sunitinib 3 Specimen Handling 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 montanide ISA 51 2 lenvatinib 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Triamcinolone Acetonide 2 Thalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06970236 2025-05-28

IHOPE

University of Valencia

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡